TickerFactsScreenerDevelopers

MiNK Therapeutics, Inc. (INKT) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2020: $95.2K2021: $249.0K2022: $250.0K2023: $73.6K$73.6K
2020Capital Expenditures (USD)2023
Fiscal YearCapital ExpendituresChange YoY
2023$73.6K-70.6%
2022$250.0K+0.4%
2021$249.0K+161.5%
2020$95.2K—